Awardee OrganizationUNIV OF NORTH CAROLINA CHAPEL HILL
Description
Abstract Text
DESCRIPTION (provided by applicant): Appropriate mechanical stimulation is crucial for maintenance of articular cartilage. Aberrant mechanical loading can lead to the initiation or progression of osteoarthritis. The mechanisms by which chondrocytes sense or respond to mechanical loading in healthy and diseased cartilage are not fully understood. Articular chondrocytes are encapsulated in a complex pericellular matrix composed mainly of fibrillar collagens, hyaluronan, proteoglycans, fibronectin and laminin. This PCM links the chondrocyte to its extracellular environment through cell surface receptors (integrins and CD44), and protects the chondrocyte from osmotic challenge and deformation during mechanical load. Preliminary data indicate that accumulation of extracellular matrix by chondrocytes in culture is concomitant with decreasing rates of ATP release and an increase in intracellular calcium mobilization in response to fluid shear (or stimulation). It is hypothesized therefore that deposition of extracellular matrix alters the mechanical responsiveness and that individual components of the pericellular matrix differentially regulate mechanotransduction in chondrocytes. This hypothesis will be tested in cultured primary chondrocytes using two novel systems: a microplate mechanotransduction assay developed by the principal investigator, and a fluorescence-coupled three-dimensional atomic force microscope capable of delivering precisely measured forces to magnetic beads. Comparison of cell signaling events initiated by chondrocytes on different substrata will help to identify key elements within the pericellular environment that modulate or control the metabolism of chondrocytes during mechanical loading in normal and diseased cartilage. Such comparison will also identify likely chondrocyte mechanoreceptors (such as integrins, or CD44), based on their relative affinities for different ECM molecules. Learning the role of specific ECM molecules in chondrocyte mechanotransduction will increase our understanding of the pathogenesis of osteoarthritis and may aid in designing novel therapies for slowing progression.
National Institute of Dental and Craniofacial Research
CFDA Code
121
DUNS Number
608195277
UEI
D3LHU66KBLD5
Project Start Date
01-July-2004
Project End Date
30-April-2006
Budget Start Date
01-July-2004
Budget End Date
30-April-2005
Project Funding Information for 2004
Total Funding
$73,000
Direct Costs
$50,000
Indirect Costs
$23,000
Year
Funding IC
FY Total Cost by IC
2004
National Institute of Dental and Craniofacial Research
$73,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R03DE015733-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R03DE015733-01A1
Patents
No Patents information available for 1R03DE015733-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R03DE015733-01A1
Clinical Studies
No Clinical Studies information available for 1R03DE015733-01A1
News and More
Related News Releases
No news release information available for 1R03DE015733-01A1
History
No Historical information available for 1R03DE015733-01A1
Similar Projects
No Similar Projects information available for 1R03DE015733-01A1